semaglutide for bariatric patients Can Take Wegovy? What the Research Says Revisional Metabolic and Bariatric Surgery

Shi, L.-Y

In selecting between these drugs, healthcare providers determine aspects such as patients' general wellbeing and symptom gravity since each drug carries risks of unwanted effects

Most guidelines recommend continuing therapy indefinitely if you tolerate it well, your weight stabilizes at a healthy range, and your cardiometabolic health improves

10.1042/BST20200270 Summary Keywords GLP-1, immunemetabolic signaling, metabolic disease, neuroendocrine peptides, orphan receptors, peptide therapeutics, polypharmacology Citation Niazi SK (2026) Beyond GLP-1: underexplored peptidereceptor systems as the next frontier in drug discovery